NCT06993844 2026-03-17Phase 1/2 Study of ETX-636 in Participants With Advanced Solid TumorsEnsem TherapeuticsPhase 1/2 Recruiting233 enrolled
NCT07109726 2026-02-27A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway AlterationsTerremoto Biosciences Inc.Phase 1/2 Recruiting205 enrolled
NCT05226871 2025-11-25Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesPfizerPhase 2 Active not recruiting35 enrolled
NCT06145308 2025-09-15Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular TypingPeking Union Medical CollegePhase 2 Recruiting39 enrolled